Decreased recovery of replication-competent HIV-1 from peripheral blood mononuclear cell-derived monocyte/macrophages of HIV-positive patients after 3 years on highly active antiretroviral therapy

AIDS

Volumn 16, Issue 9, 2002, Pages 1289-1292

  Belmonte, Liliana ^a   Baré, Patricia ^a   Picchio, Gaston R ^a   Perez Bianco, Raul ^a   De Tezanos Pinto, Miguel ^a   Corti, Marcelo ^a   Villafañe, María F ^a   De Bracco, María M E ^a   Ruibal Ares, Beatriz H ^a  

^a INST DE INVEST HEMATOLOGICAS   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERM CARE; MACROPHAGE; MONOCYTE; MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS DETECTION; VIRUS LOAD; VIRUS REPLICATION; ISOLATION AND PURIFICATION; PHYSIOLOGY; TIME; VIROLOGY;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HIV-1; HUMAN; LEUKOCYTES, MONONUCLEAR; MACROPHAGES; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; VIRUS REPLICATION; HUMANS;

EID: 0037076727     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200206140-00014     Document Type: Article

References (16)

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
2. Persistence of HIV-1 transcription in peripheral blood mononuclear cells in patients receiving potent antiretroviral therapy
3. Recovery of replication competent HIV despite prolonged suppression of plasma viremia
4. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy
5. Persistence of episomal HIV-1 infection intermediates in patients on highly active antiretroviral therapy
6. Human immunodeficiency virus type 1-infected persons with residual disease and virus reservoirs on suppressive highly active antiretroviral therapy can be stratified into relevant virologic and immunologic subgroups
7. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
8. Latent infection of CD4+ T cells provides a mechanism of lifelong persitence of HIV-1, even in patients on effective combination therapy
9. Monocytes harbor replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy
10. Residual HIV-1 infection during antiretroviral therapy: The challenge of viral persistence
11. HIV infection in macrophages. Role of long-lived cells and related therapeutic strategies
12. Monocyte differentiation and HIV replication after prolonged culture of peripheral blood mononuclear cells from HIV-infected individuals
13. HIV-1 and HAART: A time to cure, a time to kill
14. Isolation and quantitation of HIV in peripheral blood
15. HIV-1 infection in patients with hemophilia. The Argentine experience since 1983 to 1990
16. Decay characteristics of HIV-1 infected compartments during combination therapy